Objectives: To evaluate the safety, feasibility, and clinical outcomes of fractional thermal–mechanical resurfacing for treating dyschromia, roughness, and rhytides in the areola and labia majora. Attendees will learn about treatment protocols, patient-reported outcomes, and how AI-assisted image analysis compares with physician-based assessments in aesthetic evaluation of sensitive anatomical regions.
Introduction: While fractional thermal–mechanical resurfacing is established for facial rejuvenation, its application to sensitive areas like the areola and labia majora remains largely unexplored. This study investigates the safety and efficacy of such technology in addressing dyschromia, textural irregularities, and rhytides in these regions.
Materials / method: Eight patients with areolar or labial aesthetic concerns received three sessions of fractional thermal–mechanical resurfacing at monthly intervals. Standardized photographs were taken at baseline, after each treatment, and at a six-month follow-up. Blinded investigators assessed improvements in pigmentation, texture, and wrinkles using a quartile scale. Patient satisfaction was measured through structured surveys. AI-assisted image analysis was used to quantify pigmentation, roughness, and fine lines, and compared with physician-based evaluations.
Results: Clinical evaluation revealed noticeable improvements in pigmentation, skin texture, and wrinkle reduction in the treated areas following the three treatment sessions. At the six-month follow-up, the aesthetic enhancements were maintained relative to the pre-treatment baseline, demonstrating a sustained benefit. No significant adverse events were observed.
Conclusion: Fractional thermal–mechanical resurfacing demonstrates promise as a safe and effective modality for aesthetic enhancement of the areola and labia majora. The observed improvements in skin tone and texture, coupled with sustained results at six months, suggest that this modality can be a valuable tool for addressing aesthetic concerns in these less commonly treated areas. Further controlled studies with larger cohorts are warranted.
利益冲突声明
您有否接受任何资金来支持研究这个主题？
否
您是否接受过关于这项研究的任何酬金或其他报酬？
否
你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否
你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
